Buy One Get One free -Llimited Time Offer X
Tigatel is a prescription medicine that is available as a Tablet. Epilepsy are some of its major therapeutic uses. Secondary and off-label uses of Tigatel have also been mentioned below.
The optimal dosage of Tigatel is largely dependent on the individual's body weight, medical history, gender and age. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Detailed information has been provided in the dosage section.
Apart from the aforementioned side effects, Tigatel can also lead to other problems, which have been listed below. Usually, these side effects of Tigatel go away soon, and do not persist beyond the duration of the treatment. If, however, they worsen or do not go away, please speak with your physician.
It is also important to note that Tigatel has a Moderate effect for pregnant women and Unknown effect on lactating mothers. It is important to know if Tigatel has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Tigatel related warnings section.
Tigatel is contraindicated in people with pre-existing medical conditions like Liver Disease as it can result in adverse effects. The section on Tigatel contraindications lists all such conditions.
Drug interactions for Tigatel have been reported in the medical literature. See below for a complete list.
In addition to the above precautions for Tigatel, it is important to know that it is not safe while driving, and is not habit-forming.
Tigatel is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
Is the use of Tigatel safe for pregnant women?
Pregnant women may experience moderate side effects from Tigatel. It is best to stop taking Tigatel immediately and inform your doctor if you notice any discomfort.
Is the use of Tigatel safe during breastfeeding?
Information about safety of Tigatel for women who are breastfeeding is not available since scientific research on this is yet to be done.
What is the effect of Tigatel on the Kidneys?
Tigatel is not harmful for kidneys.
What is the effect of Tigatel on the Liver?
Very few cases of side effects of Tigatel on the liver have been reported.
What is the effect of Tigatel on the Heart?
Using Tigatel does not have any harmful effects on the heart.
Tigatel should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Tigatel unless your doctor advises you to do so -
Is this Tigatel habit forming or addictive?
No, there is no any evidence that Tigatel is addictive.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Tigatel can make you feel drowsy.
Is it safe?
Yes, Tigatel is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
Yes, taking Tigatel can treat mental disorders.
Interaction between Food and Tigatel
Taking Tigatel with food does not harm your health.
Interaction between Alcohol and Tigatel
Taking Tigatel with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Gabitril® (tiagabine HCl)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 421
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1202-1204